Creative BioMart to Present at
                        BIO-Europe Spring Creative BioMart to Present at IMMUNOLOGY2024™|May 3-7, 2024|Booth #512

Recombinant Human APITD1 293 Cell Lysate

Cat.No. : APITD1-8794HCL
  • Specification
  • Gene Information
  • Related Products
  • Download
Description : Antigen standard for apoptosis-inducing, TAF9-like domain 1 (APITD1), transcript variant B is a lysate prepared from HEK293T cells transiently transfected with a TrueORF gene-carrying pCMV plasmid and then lysed in RIPA Buffer. Protein concentration was determined using a colorimetric assay. The antigen control carries a C-terminal Myc/DDK tag for detection.
Source : HEK 293 cells
Species : Human
Components : This product includes 3 vials: 1 vial of gene-specific cell lysate, 1 vial of control vector cell lysate, and 1 vial of loading buffer. Each lysate vial contains 0.1 mg lysate in 0.1 ml (1 mg/ml) of RIPA Buffer (50 mM Tris-HCl pH7.5, 250 mM NaCl, 5 mM EDTA, 50 mM NaF, 1% NP40). The loading buffer vial contains 0.5 ml 2X SDS Loading Buffer (125 mM Tris-Cl, pH6.8, 10% glycerol, 4% SDS, 0.002% Bromophenol blue, 5% beta-mercaptoethanol).
Size : 0.1 mg
Storage Instruction : Store at -80°C. Minimize freeze-thaw cycles. After addition of 2X SDS Loading Buffer, the lysates can be stored at -20°C. Product is guaranteed 6 months from the date of shipment.
Applications : ELISA, WB, IP. WB: Mix equal volume of lysates with 2X SDS Loading Buffer. Boil the mixture for 10 min before loading (for membrane protein lysates, incubate the mixture at room temperature for 30 min). Load 5 ug lysate per lane.
Gene Name : APITD1?apoptosis-inducing, TAF9-like domain 1 [?Homo sapiens?(human) ]
Official Symbol : APITD1
Synonyms : APITD1; apoptosis-inducing, TAF9-like domain 1; MHF1; CENPS; CENP-S; FAAP16; centromere protein S; FANCM-interacting histone fold protein 1; Fanconi anemia-associated polypeptide of 16 kDa; apoptosis-inducing TAF9-like domain-containing protein 1
Gene ID : 378708
mRNA Refseq : NM_199294
Protein Refseq : NP_954988
MIM : 609130
UniProt ID : Q8N2Z9
Chromosome Location : 1p36.22
Pathway : Cell Cycle, organism-specific biosystem; Fanconi anemia pathway, organism-specific biosystem; M Phase, organism-specific biosystem; Resolution of Sister Chromatid Cohesion, organism-specific biosystem
Function : DNA binding; chromatin binding; contributes_to double-stranded DNA binding

For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.

Inquiry

  • Q&As
  • Reviews

Q&As (20)

Ask a question
What is the development progress of APITD1 ? 10/10/2022

The development of APITD1 may still be in its infancy, and more time and effort are needed to perfect it.

Are there known indications and contraindications? 09/12/2022

At present, the known indications and contraindications of APITD1 are not clear enough and require further study and evaluation.

What is the method and dosage of APITD1 ? 09/07/2022

The specific use method and dosage of APITD1 need to be determined according to the actual clinical situation, and it is best for doctors to guide the application.

Are there any clinical guidelines for recombinant APITD1? 07/26/2022

The current clinical guidelines on APITD1 s may not be fully mature and require more research and clinical trials to develop.

Is there currently a patent for the APITD1? 12/07/2021

At present, the patent status of APITD1 is not clear, and it is necessary to consult the relevant patent database to get accurate information.

What is the future direction of APITD1? 09/16/2021

Future directions of APITD1 may include more in-depth mechanism studies, expansion of clinical trials, and exploration of applications in multiple diseases.

What are the side effects of APITD1 ? 11/16/2020

The side effects of recombinant APITD1 are not fully understood, but with the use of any new drug, the potential risks generally need to be carefully evaluated. ⚠ ️

In what diseases might the APITD1 play a role? 08/28/2020

The APITD1 has the potential to be used in the treatment of various diseases, such as cancer and autoimmune diseases.

Can APITD1 be used alone or in combination with other treatments? 08/06/2020

The APITD1 may need to be used in combination with other therapies, which needs to be evaluated and decided on a case-by-case basis.

Has the research result of APITD1 been published in an academic journal? 07/25/2020

The current research results on the APITD1 may still be ongoing and have not been fully published in academic journals. 📚

Are there any relevant research institutes or laboratories conducting research on APITD1 ? 04/14/2020

It is possible that relevant research institutions or laboratories are conducting research on APITD1 , but the specific situation needs to be further understood.

How safe is APITD1 in clinical trials? 03/19/2020

Regarding the safety of APITD1 in clinical trials, there are still insufficient research results, and further experiments and observations are needed.

Does APITD1 have drug resistance? 03/03/2020

At present, there are insufficient research results on the resistance of APITD1 , and further studies are needed to explore this.

How to evaluate the efficacy of APITD1 ? 12/26/2019

The efficacy of APITD1 is generally determined through clinical trials and subsequent observational evaluation.

Is the mechanism and biological function of APITD1 understood? 11/18/2019

The academic community has some preliminary understanding of the mechanism and biological function of APITD1 , but further research is still needed.

Are there any APITD1 products currently on the market? 11/12/2019

It is not clear whether there are any products on the market that sell the APITD1 , but it is unlikely.

What are the pathways used by APITD1 ? Such as oral, injection, etc. 10/10/2019

The APITD1 is usually administered by injection, as oral administration may not guarantee the stability and absorbability of the drug.

What progress has been made in the research on the mechanism of APITD1 ? 10/07/2019

The mechanism of APITD1 is still being studied, but there are some preliminary studies that suggest it may play an important role in regulating immune response.

Are there any clinical trial results on APITD1 for reference? 07/03/2019

So far, clinical trials on APITD1 have been limited, but some preliminary studies suggest it may have potential.

What are the challenges in the study of APITD1? 04/22/2019

There are some challenges in the study of APITD1, such as the stability of the drug, the determination of dosage and other issues to be overcome.

Customer Reviews (4)

Write a review
Reviews
02/26/2022

    This green production method of APITD1 is not only conducive to environmental protection, but also brings long-term economic benefits to enterprises.

    07/01/2021

      Short half-life and high clearance of APITD1 provide new ideas and methods for drug development, and it is expected to become a research hotspot in the field of biomedicine in the future.

      09/27/2020

        Stability of APITD1 is very good, in a variety of application scenarios, no matter how the environment changes, it can maintain stable performance.

        05/06/2020

          APITD1 performed very well in the experiment, and the results were reliable and reproducible.

          Ask a Question for All APITD1 Products

          Required fields are marked with *

          My Review for All APITD1 Products

          Required fields are marked with *

          0

          Inquiry Basket

          cartIcon
          logo

          FOLLOW US

          Terms and Conditions        Privacy Policy

          Copyright © 2024 Creative BioMart. All Rights Reserved.

          Contact Us

          • /

          Stay Updated on the Latest Bioscience Trends